NCT05046223View on ClinicalTrials.gov

Comparison of iGel and THRIVE on Bronchoscopic Interventions

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

August 20, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

January 31, 2023

Conditions
Lung DiseasesTotal Intravenous AnesthesiaTracheal Diseases
Interventions
PROCEDURE

The responses to bronchoscopic insertion for bronchoscopic interventions such asTBNA, Cryotherapy, etc.

cough response, the changes of BP, HR, SpO2, Trans dermal CO2 during bronchoscopic interventions

PROCEDURE

postoperative recovery

anesthetic recovery in postoperative care unit recovery of swallowing by questionnaire in POD1

Trial Locations (1)

Unknown

National Taiwan University Cancer Center, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT05046223 - Comparison of iGel and THRIVE on Bronchoscopic Interventions | Biotech Hunter | Biotech Hunter